SynthesisJournal of vascular surgery. Venous and lymphatic disorders2024
A meta-analysis of the medium- to long-term outcomes in patients with chronic deep venous disease treated with dedicated venous stents.
Synthesis in Journal of vascular surgery. Venous and lymphatic disorders, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed, 1 synthesis or guideline pooled it, 7 citations in OpenAlex.
- Iliac vein stenting outcomes in non-thrombotic and thrombotic diseases: A systematic review and meta-analysis.Biomolecules & biomedicine · 2025Pooled it
- Long-term outcome of stenting for the iliac vein stenosis with ipsilateral arterio-venous graft; a case series.Renal failure · 2026Article
- Evaluation of venous anatomy after treatment with an intraluminal tissue debulking system in a porcine model.Journal of vascular surgery. Venous and lymphatic disorders · 2026Article
- Long-term efficacy following venous stenting for symptomatic iliofemoral venous obstruction: 5 year clinical and stent outcomes in a Southeast Asian population.Journal of vascular surgery. Venous and lymphatic disorders · 2026Article
- Influence of Stent Parameters and Post-Stenting Venographic Findings on Mid-Term Patency After Thrombectomy in May-Thurner Syndrome.Diagnostics (Basel, Switzerland) · 2026Article
- Resolution of a femoral arteriovenous fistula secondary to chronic Iliac vein occlusion after stenting: a case report.BMC surgery · 2026Article
- Radiofrequency-Wire Assisted Recanalization of Chronically Occluded Iliofemoral Venous Stents.Seminars in interventional radiology · 2026Review
- Outcomes Following Iliac Vein Stenting for Non-Thrombotic Iliac Vein Lesions-A Narrative Review Based on Large Sample Studies.Journal of functional biomaterials · 2025Review
- Endovenous bypass is an option in symptomatic patients with unsalvageable iliac vein stents.Journal of vascular surgery cases and innovative techniques · 2025Article
- Management of Extra-Pelvic Varicose Veins of Pelvic Origin in Female Patients.Journal of clinical medicine · 2025Review
- Interventional treatment for post-thrombotic chronic venous obstruction: Progress and challenges.Journal of vascular surgery. Venous and lymphatic disorders · 2024Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 4 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveThis review summarizes the safety profile, stent patency, and clinical effectiveness of dedicated venous stents for the treatment of chronic deep venous disease. The approaches to stenting and post-procedural management of different vascular units are also explored.
methodsThe MEDLINE and Embase databases were searched for pertinent literature published from January 2010 to January 2023. Outcomes related to post-stenting symptoms and health-related quality of life were described narratively. A meta analysis was conducted to evaluate stent patency, ulcer healing, bleeding, and 30-day stent thrombosis, and these outcomes were presented as proportion event rates.
resultsSeventeen studies were identified comprising of 2218 patients. 62.7% of individuals had post-thrombotic stenosis or occlusion. The majority of patients (78.6%) were noted to have complete occlusions of their deep veins before stenting. Eleven different dedicated venous stents were deployed. At 12 months, the primary patency rate was 83% (95% confidence interval [CI]: 76%-90%), the primary-assisted patency rate was 90% (95% CI: 85%-96%), and the secondary patency rate was 95% (95% CI: 92%-98%). A significant improvement in health-related quality of life was demonstrated after intervention. In total, 68.8% (95% CI: 52.0%-83.7%) of ulcers healed at the last follow-up. The remaining symptomatic changes were described narratively; improvements in pain, venous claudication, and edema after stenting were observed. Seventeen deaths occurred, but none were linked to the stenting procedures. A total of 159 cases (7.2% of patients) of in-stent stenosis were observed, whereas 110 stents (5.0% of patients) were occluded. The incidence of major and minor bleeding was 1.7% (95% CI: 1.0%-2.5%) and 3.2% (95% CI: 1.3%-5.6%), respectively, more commonly seen in patients undergoing hybrid intervention.
conclusionsDeep venous stenting using dedicated venous stents is a safe technique to treat chronic deep venous stenosis and/or occlusion. Within the limitations of this study, deep venous stenting is associated with good patency rates and symptomatic improvement.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.